Even as the rates of some cancers are falling, Mayo Clinic is seeing an alarming trend: the dramatic rise of skin cancer, especially among people under 40. According to a study by Mayo Clinic researchers published in the ...
Apr 2, 2012
0
0
Adding magnetic resonance imaging (MRI) to standard breast cancer screening approaches is expensive, though it could be cost effective for a group of women who may not have inherited the breast cancer susceptibility genes, ...
Mar 21, 2012
0
0
Heart disease is still the No. 1 killer of women, but 80 percent of heart disease is preventable. Although the majority of heart attacks occur in the ten years after menopause, the disease process starts much earlier. If ...
Feb 3, 2012
0
0
A study of 64,659 women, recently published in the journal Academic Radiology, found that while 1,246 of these women were at high enough breast cancer risk to recommend additional screening with MRI, only 173 of these women ...
Jan 31, 2012
0
0
In one of the largest-ever analyses of lifetime risks for cardiovascular disease (CVD), researchers have found that middle-aged adults who have one or more elevated traditional risk factors for CVD, such as high blood pressure, ...
Jan 26, 2012
0
0
Will you have a heart attack or a stroke in your lifetime? Your odds may be worse than you think.
Jan 25, 2012
0
0
A new study in today's New England Journal of Medicine reports that while an individual's risk of heart disease may be low in the next five or 10 years, the lifetime risk could still be very high, findings that could have ...
Jan 25, 2012
0
0
An increase or decrease in your blood pressure during middle age can significantly impact your lifetime risk for cardiovascular disease (CVD), according to research in Circulation: Journal of the American Heart Association.
Dec 19, 2011
0
0
There is still a one in eight lifetime risk that a woman will develop breast cancer, and the best tool against the disease remains early detection. Now, Women & infants Hospital of Rhode Island has taken the breast cancer ...
Dec 7, 2011
0
0
Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease. The ...
Dec 1, 2011
0
0
